Mustang Bio, Inc.
MBIO
$1.11
$0.021.84%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -15.75M | -23.42M | -32.06M | -40.10M | -51.60M |
| Total Depreciation and Amortization | 823.00K | 1.11M | 1.43M | 2.06M | 2.23M |
| Total Amortization of Deferred Charges | -- | 0.00 | 0.00 | -25.00K | 118.00K |
| Total Other Non-Cash Items | 4.15M | 3.16M | 1.89M | 2.60M | 2.76M |
| Change in Net Operating Assets | -628.00K | 2.48M | 1.82M | -1.53M | -2.98M |
| Cash from Operations | -11.41M | -16.67M | -26.93M | -36.99M | -49.48M |
| Capital Expenditure | -- | -30.00K | -30.00K | -64.00K | -64.00K |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 6.00M | 6.00M | 6.00M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | -50.00K | -50.00K | -50.00K |
| Cash from Investing | -- | -30.00K | 5.92M | 5.89M | 5.89M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | 0.00 | -30.38M | -30.38M |
| Issuance of Common Stock | 12.72M | 11.56M | 10.65M | 4.79M | 4.74M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.46M | -1.27M | -1.13M | -445.00K | -445.00K |
| Cash from Financing | 11.27M | 10.29M | 9.52M | -26.03M | -26.08M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -145.00K | -6.41M | -11.49M | -57.14M | -69.67M |